Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.074 AUD | -9.76% | -.--% | -79.15% |
Feb. 29 | Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 15 | Imagion Biosystems CEO Resigns | MT |
Sales 2022 | 3.07M 2.04M | Sales 2023 | 4.97M 3.31M | Capitalization | 11.59M 7.72M |
---|---|---|---|---|---|
Net income 2022 | -9M -5.99M | Net income 2023 | -12M -7.99M | EV / Sales 2022 | 8.81 x |
Net Debt 2022 | 158K 105K | Net Debt 2023 | 5.81M 3.87M | EV / Sales 2023 | 3.5 x |
P/E ratio 2022 |
-2.67
x | P/E ratio 2023 |
-0.87
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 89.59% |
1 day | -9.76% | ||
3 months | -9.76% | ||
6 months | -77.23% | ||
Current year | -79.15% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Proulx
CHM | Chairman | 66 | - |
Carmen Soikowski
COO | Chief Operating Officer | - | 21-10-31 |
Marie Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Ludvigson
BRD | Director/Board Member | 74 | 17-03-07 |
Robert Proulx
CHM | Chairman | 66 | - |
Michael Harsh
BRD | Director/Board Member | 69 | 17-02-27 |
1st Jan change | Capi. | |
---|---|---|
-79.15% | 1.6M | |
-26.08% | 16.63B | |
-40.92% | 2.92B | |
+23.88% | 1.96B | |
-9.90% | 1.5B | |
+29.92% | 1.33B | |
-17.38% | 952M | |
-29.23% | 809M | |
+2.58% | 805M | |
-22.68% | 648M |
- Stock Market
- Equities
- IBX Stock